Immunopeptidomics-guided discovery and characterization of neoantigens for personalized cancer immunotherapy. [PDF]
Cai Y+12 more
europepmc +1 more source
Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker. [PDF]
Wu R+6 more
europepmc +1 more source
Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals. [PDF]
Sledge GW+12 more
europepmc +1 more source
Orbital tumors: A retrospective analysis of cases from Iraq and orbital anatomical perspectives. [PDF]
Mohammad NK.
europepmc +1 more source
Interleukin-4 modulates type I interferon to augment antitumor immunity. [PDF]
Newnes HV+16 more
europepmc +1 more source
Histological Typing of Breast Tumors [PDF]
The WHO Histological Classification of Breast Tumors, published in 1968 has been completely revised. This second edition provides a recommended nomenclature, definitions and code numbers for both tumors and tumor-like lesions. It aims at promoting uniformity in recording and reporting diagnoses in order to facilitate international and other ...
J. Sugar+12 more
openaire +2 more sources
Related searches:
Sonography of ovarian tumors: predictability of tumor type
American Journal of Roentgenology, 1983One hundred six ovarian neoplasms were evaluated with respect to size, echogenic characteristics, and percentage of echogenic material to determine if sonography could differentiate between malignant and benign tumors and if histology could be determined.
D Rochester+4 more
openaire +3 more sources
Neurogenic Tumors in the Abdomen: Tumor Types and Imaging Characteristics
RadioGraphics, 2003There is a broad spectrum of neurogenic tumors that involve the abdomen. These tumors can be classified as those of (a) ganglion cell origin (ganglioneuromas, ganglioneuroblastomas, neuroblastomas), (b) paraganglionic system origin (pheochromocytomas, paragangliomas), and (c) nerve sheath origin (neurilemmomas, neurofibromas, neurofibromatosis ...
Hae Giu Lee+5 more
openaire +3 more sources
Firefighters for the Wrong Type of Inflammation in Tumors
Cancer Discovery, 2021Abstract Summary: In this issue of Cancer Discovery, Pelly and colleagues show that inhibition of prostaglandin E2 synthesis or its activity on EP2 and EP4 receptors synergizes with anti–PD-1 immunotherapy and triggers a potent intratumoral IFNγ response in mouse models and in fresh surgical human ...
Ignacio Melero+3 more
openaire +2 more sources